Javascript must be enabled to continue!
Morphological Diversity of the Endometrium in Choriocarcinoma Specimens and its Role in Differential Diagnosis
View through CrossRef
I
ntroduction:
The morphological characteristics of the endometrium in patients with choriocarcinoma have not been well described. We described the endometrial morphology patterns in 46 choriocarcinomas and analyzed their relationship with the clinicopathological characteristics of these patients.
Methods:
Forty-six patients diagnosed with choriocarcinoma that had sufficient endometrial tissues for histopathological diagnosis were selected. Diagnoses of choriocarcinoma and secretory status of endometrium were reviewed. LHCGR expression of endometrium was evaluated by immunostaining.
Results:
Endometrial morphology was classified as secretory or nonsecretory. The 15 secretory specimens included 2 highly secretory and 13 common secretory specimens. The 31 nonsecretory patterns included 1 hyperplasia without atypia, 7 disordered proliferations, 13 typical proliferations, and 10 resting endometria. Among these, 11 specimens with overall nonsecretory patterns showed focally weak secretory changes surrounding the choriocarcinoma lesion. Secretory patterns were observed in classic choriocarcinomas (8/17) and monomorphic choriocarcinomas (7/21) but not in scanty-trophoblast choriocarcinomas (0/8). Secretory changes appeared significantly less frequently in patients who received multi-agent chemotherapy (4/25) than in those who did not (7/14) or received single-agent chemotherapy (4/7) (
P
= 0.030). The differences in age, months since the last pregnancy, pregnancy type, recurrence, specimen type, gross diameter, human chorionic gonadotropin (hCG) levels, and expression of hCG receptors were not statistically significant.
Conclusions:
The endometrial morphologies in choriocarcinoma were diverse, including various proliferative and secretory changes, but rarely hypersecretory changes, compared to the prevailing hypersecretory endometrium in hydatidiform moles. The variety in endometrial morphology was the consequence of ovarian hormonal disturbances of the hypothalamic–pituitary–gonadal axis by hCG from choriocarcinoma. Therefore, the endometrium may serve as a clue for histopathological diagnosis of choriocarcinoma. Our study presents the largest cohort reported to date to describe the diverse spectrum of endometrial changes in choriocarcinoma patients.
Title: Morphological Diversity of the Endometrium in Choriocarcinoma Specimens and its Role in Differential Diagnosis
Description:
I
ntroduction:
The morphological characteristics of the endometrium in patients with choriocarcinoma have not been well described.
We described the endometrial morphology patterns in 46 choriocarcinomas and analyzed their relationship with the clinicopathological characteristics of these patients.
Methods:
Forty-six patients diagnosed with choriocarcinoma that had sufficient endometrial tissues for histopathological diagnosis were selected.
Diagnoses of choriocarcinoma and secretory status of endometrium were reviewed.
LHCGR expression of endometrium was evaluated by immunostaining.
Results:
Endometrial morphology was classified as secretory or nonsecretory.
The 15 secretory specimens included 2 highly secretory and 13 common secretory specimens.
The 31 nonsecretory patterns included 1 hyperplasia without atypia, 7 disordered proliferations, 13 typical proliferations, and 10 resting endometria.
Among these, 11 specimens with overall nonsecretory patterns showed focally weak secretory changes surrounding the choriocarcinoma lesion.
Secretory patterns were observed in classic choriocarcinomas (8/17) and monomorphic choriocarcinomas (7/21) but not in scanty-trophoblast choriocarcinomas (0/8).
Secretory changes appeared significantly less frequently in patients who received multi-agent chemotherapy (4/25) than in those who did not (7/14) or received single-agent chemotherapy (4/7) (
P
= 0.
030).
The differences in age, months since the last pregnancy, pregnancy type, recurrence, specimen type, gross diameter, human chorionic gonadotropin (hCG) levels, and expression of hCG receptors were not statistically significant.
Conclusions:
The endometrial morphologies in choriocarcinoma were diverse, including various proliferative and secretory changes, but rarely hypersecretory changes, compared to the prevailing hypersecretory endometrium in hydatidiform moles.
The variety in endometrial morphology was the consequence of ovarian hormonal disturbances of the hypothalamic–pituitary–gonadal axis by hCG from choriocarcinoma.
Therefore, the endometrium may serve as a clue for histopathological diagnosis of choriocarcinoma.
Our study presents the largest cohort reported to date to describe the diverse spectrum of endometrial changes in choriocarcinoma patients.
Related Results
A pilot and ex-vivo study of examination of endometrium tissue by catheter based optical coherence tomography
A pilot and ex-vivo study of examination of endometrium tissue by catheter based optical coherence tomography
Abstract
Objective
This study aimed to distinguish ex-vivo normal and abnormal endometrium tissue samples histologically by catheter based optical c...
Choriocarcinoma in tubal pregnancy: A case report
Choriocarcinoma in tubal pregnancy: A case report
Key Clinical Message
Choriocarcinoma of the fallopian tube is extremely rare and highly susceptible to early metastasis. Clinical manifestations of ectopic preg...
Expression of Estrogen and Progesterone Receptor In Perimenopausal and Postmenopausal Endometrium.
Expression of Estrogen and Progesterone Receptor In Perimenopausal and Postmenopausal Endometrium.
Background: Hormonal changes during the menopausal transition significantly influence breast tissue biology. Estrogen receptor (ER) and progesterone receptor (PR) expression are cr...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Abstract 1596: Human choriocarcinomas: Placental growth factor-dependent preclinical tumor models
Abstract 1596: Human choriocarcinomas: Placental growth factor-dependent preclinical tumor models
Abstract
Choriocarcinomas are an aggressive form of cancer that develops in the uterus from tissue that would normally become the placenta. Choriocarcinomas are a tr...
Primary non‐gestational uterine choriocarcinoma mimicking leiomyoma
Primary non‐gestational uterine choriocarcinoma mimicking leiomyoma
Uterine choriocarcinoma is a trophoblastic neoplasm that is most commonly gestational but can also be non‐gestational in origin. However, primary non‐gestational uterine choriocarc...
Tubal Choriocarcinoma Cured by Surgery Alone: A Case Report
Tubal Choriocarcinoma Cured by Surgery Alone: A Case Report
Background: Fallopian choriocarcinoma is extremely rare and is still treated with a combination of chemotherapy and surgery. We report a case of gestational fallopian tubal chorioc...
Choriocarcinoma with Pulmonary and Spinal Metastases : A Case Report
Choriocarcinoma with Pulmonary and Spinal Metastases : A Case Report
Background : Choriocarcinoma is extremely malignant tumor contains of anaplastic trophoblast and prominent hemorrhage, necrosis, and vascular invasion. Choriocarcinoma is a rare, ...

